Registered entities
Bellerophon Therapeutics, Inc.
Reg. No. 1600132United States
Innovation
10 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 140 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 3 |
Investor mix
8 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 38% |
| Private equity | 3 | 38% |
| Other / undisclosed | 2 | 25% |